CDKN2A and cancer: Finally, in our study, the most efficient test to differentiate benign and malignant melanocytic tumours was the p16-Ki-67-HMB45 combined score with a threshold value at 4 (i.e., a score inferior to 4 in favor of a benign lesion and a score of 4 or higher in favor of a malignant tumour).